What is Corti?
Corti operates at the intersection of healthcare and artificial intelligence, providing a specialized software platform designed to assist medical personnel during live patient consultations. By utilizing real-time audio processing and natural language understanding, the platform acts as a digital assistant that transcribes notes, queries medical databases, and cross-references symptom descriptions against millions of historical clinical cases. This proactive approach to clinical decision support ensures that healthcare providers can deliver optimal treatment plans with greater precision. As a leader in the health-tech sector, Corti is effectively reducing the administrative burden on clinicians while simultaneously improving patient outcomes through data-backed insights.
How much funding has Corti raised?
Corti has raised a total of $92M across 3 funding rounds:
Angel/Seed
$5M
Series A
$27M
Series B
$60M
Angel/Seed (2019): $5M, investors not publicly disclosed
Series A (2021): $27M led by Chr. Augustinus Fabrik, Hearcore, Id Invest, Vaekstfonden, and byFounders
Series B (2023): $60M supported by Atomico, EiFO, and Eurazeo
Key Investors in Corti
Atomico
Atomico is a European Venture Capital firm headquartered in London, with offices in Paris, Berlin and Stockholm. Its founder and CEO is Niklas Zennström, a serial entrepreneur who co-founded Skype and Kazaa.
Eurazeo
Headquartered in Paris and founded in 1969, Eurazeo is a leading global investment company with considerable private equity, venture capital, real estate, and private debt, supporting companies of all sizes in their development.
byFounders
byFounders VC is a community-powered early-stage venture fund that invests in globally ambitious teams connected to the Nordic and Baltic countries, providing operational expertise and a global network.
What's next for Corti?
With the successful completion of its latest financing round, Corti is well-positioned to transition from a scaling enterprise to a dominant global player in the medical AI landscape. The strategic focus will likely shift toward expanding its footprint in international markets and deepening the integration of its diagnostic algorithms within existing hospital infrastructure. By maintaining a focus on high-impact clinical applications, the company is poised to capitalize on the increasing demand for digital health transformation. Future growth will be driven by the continued refinement of its AI models and the strategic deployment of resources to support large-scale enterprise adoption, ensuring that Corti remains at the forefront of the digital health revolution.
See full Corti company page
